European Commission Approves Merck's KEYTRUDA® Plus Chemotherapy, With or Without Bevacizumab, for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 Life Science Investing
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead Plaintiff Deadline of June 14, 2022 Pharmaceutical Investing
U.S. Food and Drug Administration Approves Camzyos for the Treatment of Adults With Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP - Important Reminder for AbbVie, Inc. Investors of Securities Fraud Class Action Lawsuit Filed on their Behalf Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ERIC, VLTA and AUPH Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CABA, ERIC and ABBV Pharmaceutical Investing
DEADLINE ALERT for ABBV, MYPS, SDIG, LICY: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VLTA, IBM and AUPH Pharmaceutical Investing
Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation Pharmaceutical Investing
LAWSUITS FILED AGAINST FB, ABBV and MYPS - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
